1664P Italian Association for Medical Oncology (AIOM) guideline application in real-world: Multi-institutional based survey of adjuvant and first-line pancreatic ductal adenocarcinoma treatment in Italy (GARIBALDI) - survival analyses in the metastatic cohort

Michele Reni ,Giulia Orsi ,Letizia Procaccio ,Ilaria Bernardini ,S Cordio ,Elisa Giommoni ,Mariacristina Di Marco ,Nicola Silvestris ,Luigi Cavanna ,Francesca Galli ,Andrea Spallanzani ,Marina Macchini ,Anna Santoni ,Massimiliano Spada ,Mauro Modesti ,Francesca Bergamo ,Tiziana Pia Latiano ,L Caldirola,F Simionato,Carmine Pinto

doi:10.1016/j.annonc.2023.09.2613

Abstract

1664P Italian Association for Medical Oncology (AIOM) guideline application in real-world: Multi-institutional based survey of adjuvant and first-line pancreatic ductal adenocarcinoma treatment in Italy (GARIBALDI) - survival analyses in the metastatic cohort

Full Text